Joint (JYNT) Expected to Announce Quarterly Earnings on Thursday

Joint (NASDAQ:JYNT) is expected to issue its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $14.5020 million for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last announced its quarterly earnings data on Thursday, March 12th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.05 by $0.02. The business had revenue of $15.17 million during the quarter, compared to analyst estimates of $14.12 million. Joint had a negative return on equity of 1.28% and a net margin of 4.99%. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Joint Trading Down 1.7%

Joint stock traded down $0.15 on Tuesday, hitting $8.64. 64,112 shares of the stock traded hands, compared to its average volume of 59,117. The firm has a market cap of $123.75 million, a P/E ratio of 45.48 and a beta of 1.11. The business’s fifty day simple moving average is $8.74 and its 200 day simple moving average is $8.81. Joint has a 1 year low of $7.50 and a 1 year high of $13.47.

Insider Activity

In related news, major shareholder Charles E. Jobson purchased 15,397 shares of the stock in a transaction dated Thursday, February 12th. The stock was purchased at an average price of $8.50 per share, with a total value of $130,874.50. Following the transaction, the insider directly owned 1,645,294 shares in the company, valued at $13,984,999. This trade represents a 0.94% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders bought 16,354 shares of company stock valued at $139,139. 30.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Joint

Several large investors have recently modified their holdings of the stock. Deutsche Bank AG raised its position in shares of Joint by 1.8% in the 4th quarter. Deutsche Bank AG now owns 84,745 shares of the company’s stock worth $739,000 after purchasing an additional 1,462 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in Joint by 104.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company’s stock worth $28,000 after buying an additional 1,501 shares in the last quarter. Barclays PLC increased its holdings in Joint by 5.3% in the 4th quarter. Barclays PLC now owns 32,235 shares of the company’s stock worth $281,000 after buying an additional 1,623 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after buying an additional 1,698 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after buying an additional 1,810 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Analyst Upgrades and Downgrades

JYNT has been the subject of several recent research reports. Zacks Research lowered Joint from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Joint in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $17.00.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.